FDA Approves First Nonprescription Oral Contraceptive ‘Opill’

JHVEPhoto
FDA headquarters in Washington.

Dr. Ingrid Skop, an OB-GYN and director of medical affairs at the Charlotte Lozier Institute, said ‘there are several concerns with this progesterone-only formulation.’